No evidence Tamiflu caused deaths: FDA

U.S. regulators so far have found no evidence Roche AG’s antiflu drug Tamiflu caused the deaths of children in Japan, a U.S. Food and Drug Administration spokeswoman said on Friday.

The FDA has been studying reports of the deaths of 12 children in Japan as well as other cases of possible side effects in children who had taken Roche’s flu-fighting drug, which is in high demand as a defense against a possible avian flu pandemic in people.

FDA officials are seeking input about the reports from a panel of outside experts that is meeting Friday. The agency plans to ask the committee whether regulators should update warnings on Tamiflu or continue to monitor the drug’s safety.

Print Version
Tell-a-Friend

RELATED ARTICLES:

Moderate Use May Avert Failure of Type 2 Diabetes Drugs   Rutgers researchers identify new antibiotic target and new antibiotic mechanism   Genes affect weight loss drug effectiveness   No mental effects seen with Arimidex   Guide helps doctors manage vaccine allergies   Class of Diabetes Drugs Carries Significant Cardiovascular Risks   Medication improves alcoholics’ quality of life   Experimental drug lowers blood sugar in diabetics   Higher co-payments reduce use of antidepressants   Synthetic molecules hold promise for new family of anti-cancer drugs   Search for an HIV Vaccine Must Go On Says Expert in Light of Recent High-profile Merck Failure   When one antidepressant doesn’t work, another may